Zydus Cadila gets USFDA approval to market 0.5 mg and 1 mg g
Now open: Certificate Course in Management of Covid-19 by Govt. Of Gujarat and PlexusMDKnow more...Now open: Certificate Course in Management of Covid-19 by Govt. Of Gujarat and PlexusMDKnow more...
Zydus Cadila has received USFDA approval to market entecavir tablets in the strengths of 0.5 mg and 1 mg and is used for the treatment of Hepatitis B. Zydus has now more than 120 approvals from the USFDA and has filed over 300 abbreviated new drug applications (ANDA) since its commencement in 2003-04...


http://bit.ly/2tjLqdh
Like
Comment
Share